Find Volinanserin manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 139290-65-6, Mdl 100907, Mdl-100907, M100907, (r)-(2,3-dimethoxyphenyl)(1-(4-fluorophenethyl)piperidin-4-yl)methanol, Volinanserin [inn]
Molecular Formula
C22H28FNO3
Molecular Weight
373.5  g/mol
InChI Key
HXTGXYRHXAGCFP-OAQYLSRUSA-N
FDA UNII
EW71EE171J

Volinanserin
Volinanserin is under investigation in clinical trial NCT00464243 (Efficacy and Safety of Volinanserin on Sleep Maintenance Insomnia - Polysomnographic Study).
1 2D Structure

Volinanserin

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(R)-(2,3-dimethoxyphenyl)-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]methanol
2.1.2 InChI
InChI=1S/C22H28FNO3/c1-26-20-5-3-4-19(22(20)27-2)21(25)17-11-14-24(15-12-17)13-10-16-6-8-18(23)9-7-16/h3-9,17,21,25H,10-15H2,1-2H3/t21-/m1/s1
2.1.3 InChI Key
HXTGXYRHXAGCFP-OAQYLSRUSA-N
2.1.4 Canonical SMILES
COC1=CC=CC(=C1OC)C(C2CCN(CC2)CCC3=CC=C(C=C3)F)O
2.1.5 Isomeric SMILES
COC1=CC=CC(=C1OC)[C@@H](C2CCN(CC2)CCC3=CC=C(C=C3)F)O
2.2 Other Identifiers
2.2.1 UNII
EW71EE171J
2.3 Synonyms
2.3.1 MeSH Synonyms

1. (r)-(2,3-dimethoxyphenyl)(1-(2-(4-fluorophenyl)ethyl)piperidin-4-yl)methanol

2. 4-piperidinemethanol, Alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-, (alpha-r)-

3. Alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenylethyl))-4-piperidine Methanol

4. M100907

5. Mdl 100,907

6. Mdl 100105

7. Mdl 100907

8. Mdl-100,907

9. Mdl-100907

10. Mdl100105

2.3.2 Depositor-Supplied Synonyms

1. 139290-65-6

2. Mdl 100907

3. Mdl-100907

4. M100907

5. (r)-(2,3-dimethoxyphenyl)(1-(4-fluorophenethyl)piperidin-4-yl)methanol

6. Volinanserin [inn]

7. Mdl100907

8. Mdl-100,907

9. Mdl100.907

10. (r)-(2,3-dimethoxyphenyl)-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]methanol

11. Chembl74355

12. C22h28fno3

13. Ew71ee171j

14. M-100907

15. Mdl-100.907

16. (r)-(2,3-dimethoxy-phenyl)-{1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl}-methanol

17. (r)-(+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluoro-phenyl)ethyl]-4-piperidine Methanol

18. Mdl 100,907

19. Unii-ew71ee171j

20. Mdl 100009

21. Serotonin 5-ht2 Receptor Antagonists

22. Alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenylethyl))-4-piperidine Methanol

23. Dsstox_cid_27363

24. Dsstox_rid_82298

25. Dsstox_gsid_47363

26. Gtpl185

27. Schembl675164

28. Dtxsid6047363

29. (2,3-dimethoxy-phenyl)-{1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl}-methanol

30. Zinc598040

31. Ex-a3509

32. Tox21_300244

33. Bdbm50095027

34. Mfcd00909060

35. Akos022180892

36. (r)-(2,3-dimethoxyphenyl)(1-(2-(4-fluorophenyl)ethyl)piperidin-4-yl)methanol

37. Ncgc00247964-01

38. Ncgc00254173-01

39. Ac-36402

40. As-35103

41. Hy-14940

42. Cas-139290-65-6

43. Cs-0003646

44. S0313

45. M100907, >=98% (hplc)

46. A886060

47. Mdl 100907, (r)-(+)-

48. M 100907

49. Q7940202

50. (r)-(1-(4-fluorophenethyl)piperidin-4-yl)(2,3-dimethoxyphenyl)methanol

51. (r)-(+)-?-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperinemethanol

52. (r)-(+)-alpha-(2,3-dimethoxyphenyl)-1-[2 -(4-fluorophenyl)ethyl]-4-piperinemethanol

53. (r)-(2,3-dimethoxyphenyl)-(1-(2-p-fluorophenylethyl)-piperidine-4-yl)-methanol

54. (r)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol

55. 4-piperidinemethanol, Alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-, (+)-

56. 4-piperidinemethanol, Alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-, (alphar)-

57. (2,3-dimethoxy-phenyl)-{1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl}-methanol (m 100907)

58. (2,3-dimethoxy-phenyl)-{1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl}-methanol(mdl 100907)

59. 4-piperidinemethanol, .alpha.-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-, (.alpha.r)-

60. 4-piperidinemethanol, Alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-, (r)-

2.4 Create Date
2005-12-16
3 Chemical and Physical Properties
Molecular Weight 373.5 g/mol
Molecular Formula C22H28FNO3
XLogP33.9
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count5
Rotatable Bond Count7
Exact Mass373.20532192 g/mol
Monoisotopic Mass373.20532192 g/mol
Topological Polar Surface Area41.9 Ų
Heavy Atom Count27
Formal Charge0
Complexity422
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Serotonin Antagonists

Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)


ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty